Mesalamine 2 g Sachet for the Maintenance of Clinical and Endoscopic Remission in Ulcerative Colitis (UC)
Status:
Completed
Trial end date:
2018-09-19
Target enrollment:
Participant gender:
Summary
The purpose of this trial was to investigate the safety and efficacy of mesalamine 2 g
extended release granules (sachet) once a day (QD) for maintenance of clinical and endoscopic
remission in subjects with UC. The duration of treatment for each subject was 6 months.